Treatment of Severe Pandemic Influenza A/H1N1 Infection
Open Access
- 1 January 2009
- journal article
- Published by Korean Society of Infectious Diseases and Korean Society for Chemotherapy in Infection and Chemotherapy
- Vol. 41 (5), 265-271
- https://doi.org/10.3947/ic.2009.41.5.265
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza VirusNew England Journal of Medicine, 2009
- Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In VitroAntimicrobial Agents and Chemotherapy, 2009
- Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in MexicoNew England Journal of Medicine, 2009
- Understanding Influenza BackwardJAMA, 2009
- Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and MiceScience, 2009
- Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in FerretsScience, 2009
- In vitro and in vivo characterization of new swine-origin H1N1 influenza virusesNature, 2009
- The Signature Features of Influenza Pandemics — Implications for PolicyNew England Journal of Medicine, 2009
- Emergence and pandemic potential of swine-origin H1N1 influenza virusNature, 2009
- Effects of Double Combinations of Amantadine, Oseltamivir, and Ribavirin on Influenza A (H5N1) Virus Infections in Cell Culture and in MiceAntimicrobial Agents and Chemotherapy, 2009